Cerebrolysin Cerebrolysin occupies a different niche than the first two
Disclosure of interest: Trevor Wendt: nothing to disclose
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance
Finally, the review notes that a couple of clinical studies on TB4 for wound healing both resulted in the peptide accelerating the healing process.21 March 2024 study Interestingly, in a 2024 study, researchers found that TB-500 (Ac-LKKTETQ) didnt increase wound-healing activity, but one of its metabolites Ac-LKKTE did
Key Limitations No human-approved dosing standards exist No confirmed optimal frequency, duration, or quantity Wide variation exists between study methodologies Combined-use data is sparse compared to individual peptide data As a result, any dosing information should be interpreted solely within the context of research exploration